	US 12,083,215 B2
	Targeted delivery of aerosols of magnetized active agents
Yan Ostrovski, Beer-Sheva (IL); and Josue Sznitman, Haifa (IL)
Assigned to TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED, Haifa (IL)
Filed by TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED, Haifa (IL)
Filed on May 25, 2021, as Appl. No. 17/329,254.
Application 17/329,254 is a division of application No. 16/096,374, granted, now 11,013,682, previously published as PCT/IL2017/050472, filed on Apr. 25, 2017.
Claims priority of provisional application 62/327,324, filed on Apr. 25, 2016.
Prior Publication US 2021/0283048 A1, Sep. 16, 2021
Int. Cl. A61K 9/00 (2006.01); A61M 15/00 (2006.01); A61M 16/10 (2006.01); A61N 2/00 (2006.01)

CPC A61K 9/0009 (2013.01) [A61K 9/0073 (2013.01); A61M 15/009 (2013.01); A61M 16/10 (2013.01); A61N 2/002 (2013.01)]

19 Claims

1. An inhalable composition comprising a plurality of inhalable particles; wherein:

each of said plurality of inhalable particles comprises a magnetic element;

said magnetic element constitutes from 0.1% to 20% by volume of said inhalable particle;

said plurality of particles is characterized by an average particle size of between 100 and 750 nm; and said plurality of inhalable particles is in a form of liquid particles; and wherein said inhalable composition is formulated for delivery via inhalation.